Eagle Pharmaceuticals(EGRX) - 2020 Q4 - Annual Report
Eagle Pharmaceuticals(US:EGRX)2021-03-04 16:00UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | --- | --- | --- | |----------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------| | | For the transition period from to . \nCommission File Number 001-36306 Eagle Pharmaceuticals, Inc. ...